Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Table 2 CTCs detected in patient samples

						CTC subtype/mL
Patient ID	Extent of disease at time of draw	Days from diagnosis to draw	Cycles of chemo prior to draw	CK⁺	CK⁺ Clusters	CK^-	CK^- Clusters	Apoptotic	PD-L1+ (%)^a
B-002	MIBC	4882	2	0.0	0.0	1.1	0.0	0.0	0.0 (0.0)
B-003	MIBC	59	0	0.0	0.0	0.0	0.0	1.8	0.0 (0.0)
B-015	MIBC	58	0	1.0	0.0	0.0	0.0	1.5	0.0 (0.0)
B-018	MIBC	150	4^b	0.0	0.0	0.0	0.0	0.0	0.0 (0.0)
B-001	mBCa	55	0	3.3	0.0	2.5	0.0	0.0	0.0 (0.0)
B-004	mBCa	553	4^b	0.0	0.0	5.0	0.0	0.0	0.0 (0.0)
B-005	mBCa	225	4^b	34.7	0.3	0.7	0.0	12.5	0.3 (0.9)
B-006	mBCa	27	0	7.6	1.5	1.5	0.0	0.0	0.0 (0.0)
B-007	mBCa	162	0	0.0	0.0	0.8	0.0	1.7	0.0 (0.0)
B-010	mBCa	1513	9	1.5	0.0	3.7	0.0	0.0	0.7 (14.3)
B-011	mBCa	633	0	153.2	6.4	2002.1	38.3	0.0	972.3 (44.2)
B-012	mBCa	4606	1	5.5	0.0	5.2	0.0	6.7	0.6 (5.7)
B-013	mBCa	423	5^b	0.0	0.0	0.0	0.0	0.0	0.0 (0.0)
B-014	mBCa	43	2^b	0.0	0.0	3.3	0.0	1.6	0.0 (0.0)
B-016	mBCa	939	4^b	11.9	0.6	5.8	1.0	1.0	0.0 (0.0)
B-017	mBCa	109	0	0.0	0.0	0.0	0.0	0.8	0.0 (0.0)
B-019	mBCa	163	4^b	0.0	0.6	1.3	0.0	0.0	1.3 (66.7)
B-020	mBCa	815	8^b	4.2	0.0	0.0	0.8	1.7	0.0 (0.0)
B-022	mBCa	7119	20^b	4.3	0.0	22.9	0.0	5.7	12.9 (47.4)
B-023	mBCa	444	5	0.0	0.0	0.0	0.0	0.0	0.0 (0.0)
B-025	mBCa	1659	0	76.6	4.3	2.1	0.0	1.1	1.1 (1.3)
B-026	mBCa	724	5^b	4.2	0.0	0.0	0.0	2.1	0.0 (0.0)
B-027	mBCa	271	4^b	0	0	0	0	0	0.0 (0.0)
B-028	mBCa	247	0	0.9	0	0	0	1.8	0.0 (0.0)
B-029	mBCa	996	0	0	0	0	0	0	0.0 (0.0)

ISSN: 1471-2407